Congress ticker disclosure profile
As of July 18 at 11:36 AM EDT
Public STOCK Act rows mentioning
ELUXY
A factual page for public Congressional disclosures that reference ELUXY. Veridion shows filed rows, disclosed amount ranges, dates, and source links. It does not imply motive or wrongdoing.
90d rows
0
Feed lifetime
7
Member filers
3
Disclosed ranges
$24K
Most active member desks
6 sells vs 1 buys
Latest source-stamped receipts
Latest trade Feb 27, 2023
| Date | Member | Action | Amount | Filed | Receipt |
|---|---|---|---|---|---|
| Feb 27, 2023 | Daniel Goldman | Sell | Receipt pending ingestion | Mar 20, 2023 | Receipt pending ingestion |
| Feb 27, 2023 | Daniel Goldman | Sell | $1,001 to $15,000 | Mar 20, 2023 | Open card |
| Mar 19, 2020 | Greg Gianforte | Buy | Receipt pending ingestion | Apr 7, 2020 | Receipt pending ingestion |
| Nov 19, 2018 | Greg Gianforte | Sell | Receipt pending ingestion | Dec 11, 2018 | Receipt pending ingestion |
| Nov 19, 2018 | Greg Gianforte | Sell | $1,001 to $15,000 | Date not disclosed | Open card |
| Apr 29, 2016 | Carlos Curbelo | Sell | Receipt pending ingestion | Jun 16, 2016 | Receipt pending ingestion |
| Apr 29, 2016 | Carlos Curbelo | Sell | $1,001 to $15,000 | Date not disclosed | Open card |
Source creed
This page is assembled from public STOCK Act disclosure records in the Veridion warehouse. 3 of 7 filed rows include disclosed amount ranges (43%). Rows without ranges stay labeled. Identification only; it does not imply motive or wrongdoing.